“Connecting Discovery, Care, and Therapeutic Innovation”
Join the cureEDMD community in downtown Chicago for the first-ever conference focused on Emery-Dreifuss muscular dystrophy. The conference is open to everyone: researchers, clinicians, biotech industry leaders, EDMD advocates, patients and families.
Dates & Location
April 2–4, 2027 · Chicago, Illinois
Northwestern Medicine has secured conference space at the Hyatt Centric Chicago Magnificent Mile in downtown Chicago. The conference is planned to begin Friday mid- to late afternoon and end Sunday by early afternoon. Final timing and venue details will be confirmed here.


Hotel & Travel
Book your room at the Hyatt Centric Chicago Magnificent Mile through the conference room block. A credit card is required to secure your reservation.
The Hyatt room reservation cutoff is March 2, 2027, including ADA-accessible rooms. Staying at the Hyatt is optional; attendees are welcome to choose another hotel.
Need to arrive early or stay longer? Stays outside the April 2–4, 2027 conference dates can be arranged with advance notice. Contact the conference organizers at info@cureEDMD.org in advance so they can coordinate with the hotel.
Find parking and transportation options and local visitor information in the Northwestern Medicine visitor guide.
Attend the Conference
Registration is now open. There is no conference registration fee.
Please sign up by March 28, 2027. Accessibility, hotel, and meal requests have earlier deadlines.
Please review the cureEDMD EDMD Conference Privacy Notice before registering.
Plan Ahead: Key Dates
- February 23, 2027 — Conference accessibility needs: Our venue cannot accommodate conference accessibility requests received after February 23, 2027. Please provide this information by February 23 to enable accommodation.
- March 2, 2027 — Hotel reservations: Reserve your room at the Hyatt by this date, including any ADA-accessible room.
- March 24, 2027 — Meal requirements and preferences: Please Include all food allergies and special meal requirements or preferences, including Kosher or Halal meals. Our venue cannot accommodate requests for special dietary needs and preferences received after March 24, 2027.
- March 28, 2027 — Sign-up closes: Complete your conference sign-up by this date.
For meal requests or conference accessibility needs, email info@cureEDMD.org by the applicable deadline.
Agenda
Friday afternoon, April 2, 2027
- 12:00–2:00 pm: Registration
- 2:00–2:15 pm: Welcome and general introduction
- 2:15–3:30 pm: Brief summary of current knowledge in EDMD
- Brief overview of EDMD
- Potential disease mechanisms
- Patient perspectives
- 3:30–4:00 pm: Break
- 4:00–5:00 pm: Overview of state of the art current treatment approaches
- 5:00–6:00 pm: Round table topic discussion
- Including clinical care discussion with families
- 6:00 pm: Dinner
Saturday, April 3, 2027
- Breakfast on your own
- 9:00–10:30 am: Current knowledge of disease mechanisms
- Research presentations with a focus on insights relevant for clinical translation
- 10:30–11:00 am: Break
- 11:00 am–12:00 pm: New models to study EDMD
- 12:00–1:00 pm: Lunch
- 1:00–1:45 pm: Poster session
- 2:00–3:30 pm: Lessons learned from therapeutic strategies for other muscle diseases
- 3:30–4:00 pm: Break
- 4:00–5:00 pm: Towards clinical studies: natural history studies, patient registries, clinical endpoints, data collection, and clinical registries
- 5:00–6:00 pm: Reception and networking
- 6:00 pm: Dinner
Sunday, April 4, 2027
- Breakfast on your own
- 9:00–10:30 am: Novel therapies for EDMD
- 10:30–11:00 am: Break
- 11:00–11:45 am: Next steps and future endeavors
- Discussions of key lessons from the conference and steps towards translation and therapies
- 12:00 pm: Departure
Expected Speakers to Date (More Pending):
- Gisele Bonne, Institute Myology, France
- James Holaska, Rowan University
- Jan Lammerding, Cornell University
- Kathy Mathews, University of Iowa
- Elizabeth McNally, Northwestern University
- Mark Mercola, Stanford University
- Ray Mills, cureEDMD
- Antoine Muchir, Institute Myology, France
- Richard Novak, Unravel Biosciences
- Dan Rodgers, AAVogen
- Karim Wahbi, Paris Cité University
- Lori Wallrath, University of Iowa
- Howard Worman, Columbia University
